HBT Financial (HBT) Q1 2026 earnings review
CNB Merger Delivers Immediate Margin Expansion, Masking Organic Loan Contraction
HBT Financial successfully integrated CNB Bank Shares in Q1, radically expanding its balance sheet by $1.8 billion. While $15.7 million in one-time acquisition costs suppressed GAAP net income to $11.2 million, core profitability is accelerating. By aggressively liquidating CNB's lower-yielding securities to pay down expensive debt, HBT expanded its tax-equivalent Net Interest Margin (NIM) by 9 basis points to a robust 4.25%. Organic loan and deposit growth slipped sequentially due to multi-family payoffs and off-balance-sheet wealth management shifts, but an adjusted ROATCE of 15.89% proves the core banking machine remains highly efficient post-merger.
🐂 Bull Case
Management executed a textbook balance sheet optimization post-merger, dumping low-yield CNB securities to extinguish costly funding. Yield on debt securities rose 20 bps, expanding tax-equivalent NIM to 4.25%.
Despite the GAAP noise of the transaction, Adjusted EPS grew to $0.68 (+11% YoY), indicating the deal is generating immediate cash flow returns and validating management's acquisition strategy.
🐻 Bear Case
Beneath the headline $1.2 billion loan jump, organic loans shrank by $65.6 million. Refinancing payoffs in the multi-family and CRE segments outweighed seasonal agricultural draws.
Tangible Book Value Per Share dropped 1.1% sequentially to $17.01. The decline was driven by the acquisition premium, aggressive stock buybacks, and AOCI impacts from higher market interest rates.
⚖️ Verdict: 🟢
Bullish. The successful integration of CNB Bank Shares and the associated balance sheet restructuring generated excellent core earnings power. The drop in organic loan volume is a minor, expected cyclical headwind compared to the structural margin expansion achieved this quarter.
Key Themes
NIM Expansion Driven by Acquired Asset Liquidation
Accelerating. HBT used the CNB acquisition to optimize its funding base. By selling the vast majority of the acquired CNB securities portfolio, management paid down higher-cost funding sources. This maneuver drove a 20 bps improvement in debt securities yields (to 3.01%) and outpaced a slight 2 bps rise in funding costs, widening tax-equivalent NIM by 9 bps sequentially.
Underlying Organic Loan Contraction
Decelerating. Total loans spiked to $4.69B due to the $1.30B injected by the CNB merger. However, excluding CNB, the legacy loan portfolio declined by $65.6M. The contraction was driven by large payoffs in multi-family and non-owner occupied CRE segments. While offset slightly by $26.3M in seasonal grain elevator draws, the core loan growth engine is currently stalled.
Asset Quality Softening via Acquisition
Stable to slightly decelerating. Nonperforming assets jumped from $8.7M (0.17% of total assets) in 25Q4 to $14.4M (0.21%) in 26Q1. The $5.7M increase is almost entirely attributable to the CNB merger, which brought $6.1M in NPAs, primarily within the construction and land development segment. While 0.21% remains fundamentally healthy, the mix deterioration requires monitoring.
Wealth Management Revenue Surges
Accelerating. Noninterest income rose 17.6% YoY, heavily supported by Wealth Management fees. Fees hit $3.76M, up $0.4M sequentially and $0.9M YoY, driven by higher assets under management following the CNB merger and the strategic off-boarding of $85M in wealth management deposits to capitalize on market yields.
Other KPIs
Accelerating. Jumped from 14.97% in 25Q4. Despite a 1.1% decline in absolute Tangible Book Value per share (to $17.01), the adjusted profitability generated by the core banking unit remains exceptionally strong, well above industry averages.
Reversing. Down from a positive provision of $1.46M in 25Q4. The negative provision was primarily driven by a $0.3M decrease in specific reserves, signaling management's confidence in the legacy credit portfolio despite the NPAs inherited from CNB.
Management actively managed the capital stack this quarter. They successfully issued $85M of 5.75% Fixed-to-Floating Tier 2 Subordinated Notes to fortify liquidity post-merger. Simultaneously, they aggressively bought back 602,855 shares at an average price of $25.84, leaving $14.4M on the current authorization.
Guidance
Decelerating organically. In Q4 2025, management guided for low single-digit growth for 2026, noting Q1 would be 'slightly down due to seasonal paydowns.' The $65.6M organic contraction in 26Q1 perfectly aligns with this prior guidance, putting the burden on H2 2026 to deliver the promised net organic growth.
Accelerating. Prior guidance suggested modest NIM expansion assuming Fed rate cuts. HBT vastly over-delivered in Q1, expanding tax-equivalent NIM by 9 bps to 4.25%, not entirely through macro rates, but through aggressive post-merger balance sheet structuring.
Decelerating. The prior guidance of $32M-$34M is now void due to the CNB acquisition. Excluding the $15.7M in one-time acquisition costs, the new quarterly run-rate for base costs is approximately $36.7M, reflecting added salaries and higher medical benefits.
Key Questions
M&A Appetite
With the CNB integration seemingly completed rapidly regarding core systems, how soon would you consider engaging in another acquisition, given your comment on 'attractive acquisition opportunities should the right opportunity arise'?
Organic Loan Pipeline
Excluding the CNB acquisition, legacy loans shrank due to multi-family and CRE payoffs. What does the organic origination pipeline look like for Q2 and Q3 to offset these continued refinancing headwinds?
Construction & Land Development Risk
The CNB merger brought over $6M in nonperforming assets, heavily concentrated in construction and land development. What is your strategy for working out these specific assets, and do you foresee further markdowns required?